Euclidean Capital LLC 13F: Quarter-over-Quarter Portfolio Changes
Euclidean Capital LLC reported a disclosed portfolio value of approximately $439.8 million in its latest SEC Form 13F-HR filing for Q2 2026, up 12.1% quarter on quarter. Over the quarter, the family office initiated 1 new position.
Euclidean Capital LLC's top buy was a new stake in Teamshares INC (TMS) , equal to 2.1% of the disclosed portfolio.
New PositionsQ2 2026
Securities disclosed for the first time in Q2 2026 that were not present in the prior 13F-HR filing.
| Company | Ticker | Initial Portfolio Weight | History |
|---|---|---|---|
| TEAMSHARES INC | TMS | 2.1% | History → |
Net Portfolio Value ChangeQ2 2026
- $0.4BPrior quarter
- $0.4BCurrent quarter
- +$0.0BNet delta
- +12.1%% change
Methodology & FAQ
How Euclidean Capital LLC Quarterly Changes Are Computed
All deltas are sourced from sequential SEC Form 13F-HR filings for Euclidean Capital LLC: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description, including how confidential treatment filings are handled, is documented in the Methodology.
What stocks did Euclidean Capital LLC buy in Q2 2026?
In Q2 2026, Euclidean Capital LLC initiated 1 new position (TEAMSHARES INC (TMS)).
What stocks did Euclidean Capital LLC sell in Q2 2026?
Euclidean Capital LLC reported no full exits or share-count reductions in its Q2 2026 13F filing.
Which positions did Euclidean Capital LLC initiate in Q2 2026?
Euclidean Capital LLC established 1 new position in Q2 2026: TEAMSHARES INC (TMS, 2.1%).
Which existing positions saw the largest allocation increases for Euclidean Capital LLC in Q2 2026?
Euclidean Capital LLC reported no material allocation increases in existing positions in Q2 2026.
Which positions did Euclidean Capital LLC fully exit in Q2 2026?
Euclidean Capital LLC fully exited no positions in Q2 2026.
Which existing positions saw the largest allocation reductions for Euclidean Capital LLC in Q2 2026?
Euclidean Capital LLC reported no material allocation reductions in existing positions in Q2 2026.
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.